• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

颈动脉网继发早期复发性卒中的重复静脉溶栓治疗：病例报告

Repeated intravenous thrombolysis in early recurrent stroke secondary to carotid web: Case report.

作者信息

Bouchal Siham, Lamrani Youssef Alaoui, Chtaou Naima, Maaroufi Mustafa, Belahsen Faouzi

机构信息

Department of Neurology, Hassan II University Teaching Hospital, Sidi Harazem Road, PO Box 1835, Fez, 30070 Morocco.

Laboratory of Epidemiology, Clinical Research, and Health Community, Faculty of Medicine and Pharmacy, Sidi Mohammed Ben Abdallah University, Fez, Morocco.

出版信息

Radiol Case Rep. 2021 Jan 28;16(4):843-846. doi: 10.1016/j.radcr.2021.01.026. eCollection 2021 Apr.

DOI:10.1016/j.radcr.2021.01.026
PMID:33552336
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7847828/
Abstract

Intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) is the first effective approved treatment for reducing ischemic stroke disability, and having a stroke within 3 months is usually a contraindication to thrombolysis. In this paper, we describe the case of a 58-year-old patient who received repeated intravenous thrombolysis at 10 days interval for a recurrent ischemic stroke, with dramatic improvement. The carotid diaphragm was behind this recurrent stroke and it was treated by stenting.

摘要

重组组织型纤溶酶原激活剂（rt-PA）静脉溶栓是首个被批准用于减轻缺血性卒中残疾的有效治疗方法，在3个月内发生卒中通常是溶栓的禁忌证。在本文中，我们描述了一名58岁患者的病例，该患者因复发性缺血性卒中每隔10天接受一次重复静脉溶栓，病情显著改善。颈动脉隔膜是此次复发性卒中的病因，通过支架置入术进行了治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ed0/7847828/a6c4e17f5198/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ed0/7847828/92ae92991182/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ed0/7847828/55e560b8204d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ed0/7847828/a6c4e17f5198/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ed0/7847828/92ae92991182/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ed0/7847828/55e560b8204d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ed0/7847828/a6c4e17f5198/gr3.jpg

相似文献

1
Repeated intravenous thrombolysis in early recurrent stroke secondary to carotid web: Case report.颈动脉网继发早期复发性卒中的重复静脉溶栓治疗：病例报告
Radiol Case Rep. 2021 Jan 28;16(4):843-846. doi: 10.1016/j.radcr.2021.01.026. eCollection 2021 Apr.
2
Adverse outcome of early recurrent ischemic stroke secondary to atrial fibrillation after repeated systemic thrombolysis.反复全身溶栓治疗后房颤继发早期复发性缺血性卒中的不良结局
Case Rep Vasc Med. 2013;2013:371642. doi: 10.1155/2013/371642. Epub 2013 Aug 6.
3
Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).重组组织型纤溶酶原激活剂静脉溶栓治疗急性半球性卒中。欧洲急性卒中协作研究（ECASS）。
JAMA. 1995 Oct 4;274(13):1017-25.
4
Intravenous thrombolysis for acute ischemic stroke occurring during hospitalization for transient ischemic attack.短暂性脑缺血发作住院期间发生急性缺血性卒中的静脉溶栓治疗
Int J Stroke. 2014 Jun;9(4):413-8. doi: 10.1111/ijs.12125. Epub 2013 Aug 26.
5
Repeated intravenous thrombolysis after recurrent stroke. A case series and review of the literature.复发性卒中后重复静脉溶栓治疗。病例系列及文献综述。
J Neurol Sci. 2014 Oct 15;345(1-2):181-3. doi: 10.1016/j.jns.2014.07.039. Epub 2014 Jul 23.
6
Early recurrent ischemic stroke complicating intravenous thrombolysis for stroke: incidence and association with atrial fibrillation.早期复发性缺血性卒中合并静脉溶栓治疗的卒中：发生率及与心房颤动的关系。
Stroke. 2010 Sep;41(9):1990-5. doi: 10.1161/STROKEAHA.109.569459. Epub 2010 Aug 12.
7
Nonatrial Fibrillation was Associated With Early Neurological Improvement After Intravenous Thrombolysis With rt-PA in Patients With Acute Ischemic Stroke.非房颤与急性缺血性卒中患者静脉注射rt-PA溶栓后早期神经功能改善相关。
Neurologist. 2020 Mar;25(2):28-32. doi: 10.1097/NRL.0000000000000261.
8
Intravenous thrombolysis for acute ischemic stroke associated to extracranial internal carotid artery occlusion: the ICARO-2 study.急性缺血性脑卒中合并颅外颈内动脉闭塞的静脉溶栓治疗：ICARO-2 研究。
Cerebrovasc Dis. 2012;34(5-6):430-5. doi: 10.1159/000345081. Epub 2012 Dec 1.
9
Is acute reperfusion therapy safe in acute ischemic stroke patients who harbor unruptured intracranial aneurysm?急性脑梗死伴未破裂颅内动脉瘤患者行急性再灌注治疗安全吗？
Int J Stroke. 2015 Oct;10 Suppl A100:113-8. doi: 10.1111/ijs.12616. Epub 2015 Sep 17.
10
Benefits of intravenous thrombolysis in acute ischemic stroke related to extra cranial internal carotid dissection. Dream or reality?颅外颈内动脉夹层相关急性缺血性脑卒中静脉溶栓的获益：梦想还是现实？
Int J Stroke. 2012 Jan;7(1):7-13. doi: 10.1111/j.1747-4949.2011.00637.x. Epub 2011 Oct 21.

引用本文的文献

1
Alteplase in early recurrent ischemic stroke: A case reevaluating the 3-month exclusion criteria for thrombolysis.阿替普酶用于早期复发性缺血性卒中：一例重新评估溶栓3个月排除标准的病例
Brain Circ. 2025 May 21;11(3):243-246. doi: 10.4103/bc.bc_170_24. eCollection 2025 Jul-Sep.
2
Repeated intravenous thrombolysis in recurrent ischemic stroke within 3 months: a systematic review.3 个月内反复发作缺血性脑卒中患者重复静脉溶栓治疗：系统评价。
BMC Neurol. 2023 Nov 27;23(1):422. doi: 10.1186/s12883-023-03472-4.
3
Meta-Analysis of Predictive Role of Early Neurological Deterioration after Intravenous Thrombolysis.

本文引用的文献

1
Safety and Efficacy of Repeated Thrombolysis with Alteplase in Early Recurrent Ischemic Stroke: A Systematic Review.早期复发性缺血性卒中中重复使用阿替普酶溶栓的安全性和疗效：系统评价。
J Stroke Cerebrovasc Dis. 2019 Oct;28(10):104290. doi: 10.1016/j.jstrokecerebrovasdis.2019.07.006. Epub 2019 Jul 29.
2
Recurrent ischemic stroke: Incidence, predictors, and impact on mortality.复发性缺血性卒中：发生率、预测因素及其对死亡率的影响。
Acta Neurol Scand. 2019 Jul;140(1):3-8. doi: 10.1111/ane.13093. Epub 2019 Apr 11.
3
Why not Intravenous Thrombolysis in Patients with Recurrent Stroke within 3 Months?
静脉溶栓后早期神经功能恶化预测作用的Meta分析
Emerg Med Int. 2022 Jul 22;2022:2894426. doi: 10.1155/2022/2894426. eCollection 2022.
4
Repeated Intravenous Thrombolysis in Patients with Recurrent Ischemic Stroke in the Vertebrobasilar Territory.椎基底动脉供血区复发性缺血性卒中患者的重复静脉溶栓治疗
Case Rep Neurol. 2021 Jul 29;13(2):510-514. doi: 10.1159/000518193. eCollection 2021 May-Aug.
为何不在3个月内复发性卒中患者中进行静脉溶栓治疗？
Aging Dis. 2018 Apr 1;9(2):309-316. doi: 10.14336/AD.2017.0406. eCollection 2018 Apr.
4
Carotid Web (Intimal Fibromuscular Dysplasia) Has High Stroke Recurrence Risk and Is Amenable to Stenting.颈动脉嵴（内膜纤维肌发育不良）具有较高的卒中复发风险且适合进行支架置入术。
Stroke. 2017 Nov;48(11):3134-3137. doi: 10.1161/STROKEAHA.117.019020. Epub 2017 Oct 10.
5
Carotid artery web and ischemic stroke: A case-control study.颈动脉膜与缺血性卒中：一项病例对照研究。
Neurology. 2017 Jan 3;88(1):65-69. doi: 10.1212/WNL.0000000000003464. Epub 2016 Nov 18.
6
Thrombolysis and Thrombectomy for Acute Ischemic Stroke: Strengths and Synergies.急性缺血性卒中的溶栓和取栓治疗：优势与协同作用
Semin Thromb Hemost. 2017 Mar;43(2):185-190. doi: 10.1055/s-0036-1585078. Epub 2016 Jul 29.
7
Prediction of Early Recurrence After Acute Ischemic Stroke.急性缺血性脑卒中后早期复发的预测。
JAMA Neurol. 2016 Apr;73(4):396-401. doi: 10.1001/jamaneurol.2015.4949.
8
Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association.静脉注射阿替普酶用于急性缺血性脑卒中的纳入和排除标准的科学依据：美国心脏协会/美国卒中协会医疗保健专业人员的声明。
Stroke. 2016 Feb;47(2):581-641. doi: 10.1161/STR.0000000000000086. Epub 2015 Dec 22.
9
Absolute and Relative Contraindications to IV rt-PA for Acute Ischemic Stroke.急性缺血性卒中静脉注射重组组织型纤溶酶原激活剂的绝对和相对禁忌证。
Neurohospitalist. 2015 Jul;5(3):110-21. doi: 10.1177/1941874415578532.
10
Repeated intravenous thrombolysis after recurrent stroke. A case series and review of the literature.复发性卒中后重复静脉溶栓治疗。病例系列及文献综述。
J Neurol Sci. 2014 Oct 15;345(1-2):181-3. doi: 10.1016/j.jns.2014.07.039. Epub 2014 Jul 23.